The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy.

  • A Wehnert
  • Published 1998 in International clinical psychopharmacology
Well-controlled clinical trials, although essential for registration purposes, often fail to reflect the real-life usage of a drug. Ultimately, it is how a new medicinal product is used in clinical practice, how it performs in everyday life and how the patient who takes it feels and functions that determine the real benefit: risk ratio of the drug. Such a… CONTINUE READING